Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Clin Microbiol Infect. 2014 Nov 23;21(4):387.e5–387.e8. doi: 10.1016/j.cmi.2014.11.012

TABLE 2.

Patient immunological, serological and virological profiles.

Patient
ID#
Gender Age
(years)
CD4
(cells/
mL)
Hbe
Ag
HDV
Ab
HBV DNA
plasma
log10 IU/mL
HBV DNA
CSF
log10 IU/mL
HIV RNA
plasma
log10 c/mL
HIV RNA
CSF
log10 c/mL
Albumin
index
(N < 9)
CSF
albumin
levels (g/L)
CSF pleocytosis
(WBC/mL of CSF)
Previous
cART
Length of current
exposure to 3TC
(months)
Neurological
diagnosis
MRI
demyelinating
lesions
1 M 21 7 N/A N/A 9.46 4.7 4.61 4.3 10.81 0.4 4 no HIVE yes
2 F 16 125 pos N/A 8.84 3.36 6.01 2.48 N/A N/A N/A yes stroke yes
3 M 18 37 N/A N/A 8.72 4.69 2.79 2.6 18.86 0.66 46 yes 5 stroke yes
4 M 17 490 pos N/A 8.24 5.58 5.11 5.85 27.73 0.99 5 yes HIVE yes
5 M 17 220 N/A N/A 7.65 5.36 4.18 3.44 17.55 0.66 N/A no viral encephalitis no
6 F 15 8 N/A N/A 7.54 3.42 4.58 2.72 2.62 0.1 3 no viral encephalitis yes
7 F 20 59 pos neg 6.87 4.12 5.92 5.78 8.88 0.3 10 yes 2 CMV encephalitis yes
8 M 14 13 pos neg 6.34 3.3 5.34 4.36 12.35 0.4 5 No Tx
9 M 17 1 pos neg 5.77 4.91 5.61 2.89 73.33 1.98 20 yes SME yes
10 M 15 182 pos neg 5.73 2.98 5.15 2.59 15.31 0.66 1 yes facial paresis normal
11 F 20 348 pos N/A 5.73 1.78 4.11 3.32 6.01 0.2 3 no HIVE
12 M 16 380 pos N/A 5.07 1.78 2.25 2.25 2.06 0.1 3 yes 60 stroke
13 M 14 19 pos neg 4.85 1.78 5.82 3.69 2.78 0.1 1 yes 49 PML yes
14 F 20 231 neg N/A 4.6 2.26 3.6 2.6 2.49 0.1 4 yes 13 SME yes
15 M 15 7 pos N/A 3.38 1.78 2.6 2.6 16.92 0.66 3 yes 1 PML yes
16 M 16 306 pos pos 3.24 1.78 2.6 2.6 2.65 0.1 2 yes 9 behaviour changes no
17 M 17 16 neg pos 3.15 1.78 4.8 2.6 2.53 0.1 1 yes 29 SME yes
18 F 18 325 neg neg 3.03 1.78 3.79 2.25 18.33 0.66 6 yes 36 epilepsy normal
19 F 16 8 pos pos 1.78 1.78 3.2 2.6 2.90 0.1 3 yes 45 evaluation Hodgkin
lymphoma
normal
20 F 16 305 neg N/A 1.78 1.78 3.62 4 33.08 1.32 22 yes viral encephalitis
21 M 16 1 neg pos 1.78 1.78 2.25 2.43 3.65 0.1 3 yes 42 SME yes
22 F 18 220 neg neg 1.78 1.78 1.7 1.7 2.54 0.1 12 yes 22 HIVE no
23 M 18 738 N/A N/A 1.78 1.78 1.7 1.7 2.45 0.1 2 yes 69 HIVE
24 F 20 406 neg neg 1.78 1.78 1.67 1.67 2.34 0.1 2 yes 24 HIVE
25 F 19 255 neg neg 1.78 1.78 2.72 1.7 2.38 0.1 4 yes 9 HIVE
26 M 21 146 neg neg 1.78 1.78 4.8 5.1 6.90 0.2 22 no HIVE yes

Abbreviations: HBe Ag, hepatitis B e antigen; HDV Ab, hepatitis D virus antibodies; HBV, hepatitis B virus; CSF, cerebrospinal fluid; WBC, white blood cells; cART, combination antiretroviral therapy; HIVE, HIV encephalopathy; SME, measles inclusion body encephalitis or subacute myoclonic measles encephalitis; PML, progressive multifocal leucoencephalopathy; Tx, cerebral toxoplasmosis.